ONCE - Spark Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
69,878
64,725
12,066
20,183
Cost of Revenue
11,931
7,915
-
-
Gross Profit
57,947
56,810
-
-
Operating Expenses
Research Development
159,822
125,554
143,764
97,512
Selling General and Administrative
148,457
124,895
111,123
48,070
Total Operating Expenses
308,279
250,449
254,888
145,582
Operating Income or Loss
-250,332
-193,639
-242,822
-125,399
Interest Expense
-
-
-
-
Total Other Income/Expenses Net
-10,015
104,922
-15,696
-11,132
Income Before Tax
-250,306
-78,723
-254,445
-123,653
Income Tax Expense
141
99
-963
-
Income from Continuing Operations
-250,447
-78,822
-253,482
-123,653
Net Income
-250,447
-78,822
-253,482
-123,653
Net Income available to common shareholders
-250,447
-78,822
-253,482
-123,653
Reported EPS
Basic
-
-2.11
-7.63
-4.29
Diluted
-
-2.11
-7.63
-4.29
Weighted average shares outstanding
Basic
-
37,367
33,242
28,804
Diluted
-
37,367
33,242
28,804
EBITDA
-
-186,721
-237,961
-121,765